Gastrointestinal Colonization of Carbapenem-Resistant Acinetobacter baumannii: What Is the Implication for Infection Control?

被引:6
|
作者
Wong, Shuk-Ching [1 ]
Chen, Jonathan Hon-Kwan [2 ]
Chau, Pui-Hing [3 ]
So, Simon Yung-Chun [2 ]
Auyeung, Christine Ho-Yan [1 ]
Lai-Ha Yuen, Lithia [1 ]
Chan, Veronica Wing-Man [1 ]
Lam, Germaine Kit-Ming [1 ]
Chiu, Kelvin Hei-Yeung [2 ]
Ho, Pak-Leung [4 ]
Lo, Janice Yee-Chi [5 ]
Yuen, Kwok-Yung [4 ]
Cheng, Vincent Chi-Chung [1 ,2 ]
机构
[1] Queen Mary Hosp, Hong Kong West Cluster, Infect Control Team, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Dept Microbiol, Hong Kong, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Peoples R China
[5] Ctr Hlth Protect, Dept Hlth, Hong Kong, Peoples R China
来源
ANTIBIOTICS-BASEL | 2022年 / 11卷 / 10期
关键词
carbapenem-resistant Acinetobacter baumannii; multidrug-resistant Acinetobacter baumannii; gastrointestinal colonization; infection control; PREVENT NOSOCOMIAL TRANSMISSION; ENVIRONMENTAL CONTAMINATION; HAND HYGIENE; OUTBREAK; ENTEROBACTERIACEAE; SURVEILLANCE; CORONAVIRUS; HOMES; AIR;
D O I
10.3390/antibiotics11101297
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The epidemiology of patients with gastrointestinal colonization of carbapenem-resistant Acinetobacter baumannii (CRAB) has not been systematically analyzed. We aimed to analyze the incidence, risk factors, and clinical outcomes of patients with newly identified gastrointestinal colonization of CRAB in a healthcare region in Hong Kong, where a multi-pronged screening strategy for gastrointestinal colonization of CRAB, together with other multidrug-resistant organisms (MDROs), was conducted by collecting fecal specimens (rectal swab or stool) upon admission and during hospitalization. From 1 October 2015 to 31 December 2019, a total of 161,339 fecal specimens from 63,588 patients, 61,856 (97.3%) of whom were hospitalized patients, and 54,525 (88.1%) were screened upon admission, with 1309 positive for CRAB (2.4% prevalence). Among patients positive for CRAB in fecal specimens, 698 (53.3%) had newly detected gastrointestinal colonization of CRAB, giving an incidence of 10.03 per 10,000 patient admissions and constituting 2646 CRAB colonization days in the general wards. Excluding the 164 patients with co-colonization of other MDROs, 534 patients had gastrointestinal colonization with only CRAB, and 12.5% (67/534) developed symptomatic CRAB infections at a median of 61 days (range: 2 to 671 days), during prospective follow-up for 2 years. Compared with age- and sex-matched controls, patients being referred from residential care homes for the elderly, the presence of indwelling devices, use of beta-lactam/beta-lactamase inhibitors, carbapenems, and proton pump inhibitors in the preceding 6 months, and history of hospitalization in the past 6 months were significantly associated with gastrointestinal colonization with CRAB, as shown by multivariable analysis. Log-rank test showed that cases had significantly shorter survival duration than controls (p < 0.001). The adjusted hazard ratio of gastrointestinal colonization of CRAB was 1.8 (95% CI: 1.5-2.2; p < 0.001), as shown by Cox regression analysis. Whole-genome sequencing of eight patients with CRAB isolates in their blood cultures and rectal swabs during the same episode of hospitalization revealed ST-195 as the predominant type, as shown by multilocus sequencing type. Gastrointestinal colonization of CRAB poses a considerable challenge for infection prevention and control.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
    Carmi Bartal
    Kenneth V. I. Rolston
    Lior Nesher
    [J]. Infectious Diseases and Therapy, 2022, 11 : 683 - 694
  • [2] Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
    Bartal, Carmi
    Rolston, Kenneth V., I
    Nesher, Lior
    [J]. INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 683 - 694
  • [3] Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization
    Peghin, Maddalena
    Givone, Filippo
    de Martino, Maria
    Ali, Raja Waqar
    Graziano, Elena
    Isola, Miriam
    Grossi, Paolo Antonio
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024,
  • [4] Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case–control study
    O. Henig
    G. Weber
    M. B. Hoshen
    M. Paul
    L. German
    A. Neuberger
    I. Gluzman
    A. Berlin
    C. Shapira
    R. D. Balicer
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 2063 - 2068
  • [5] Screening for Carbapenem-Resistant Acinetobacter baumannii Colonization Sites: An Implication for Combination of Horizontal and Vertical Approaches
    Apisarnthanarak, Anucha
    Warren, David K.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (07) : 1057 - 1059
  • [6] Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates
    Roy, S.
    Viswanathan, R.
    Singh, A.
    Das, P.
    Basu, S.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (12) : 1495 - 1500
  • [7] Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates
    S. Roy
    R. Viswanathan
    A. Singh
    P. Das
    S. Basu
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 1495 - 1500
  • [8] The Rise of Carbapenem-Resistant Acinetobacter baumannii
    Evans, Benjamin A.
    Hamouda, Ahmed
    Amyes, Sebastian G. B.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (02) : 223 - 238
  • [9] Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study
    Henig, O.
    Weber, G.
    Hoshen, M. B.
    Paul, M.
    German, L.
    Neuberger, A.
    Gluzman, I.
    Berlin, A.
    Shapira, C.
    Balicer, R. D.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (10) : 2063 - 2068
  • [10] DIRECT ECONOMIC BURDEN AND OUTCOMES AMONG PATIENTS WITH CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII INFECTION OR COLONIZATION
    Huang, W.
    Zong, Z.
    Qiao, F.
    Chen, Y.
    Yin, W.
    Dong, P.
    Lin, J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A215 - A215